Glycoside derivatives and uses thereof
US-2015141354-A1 · May 21, 2015 · US
US9895389B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9895389-B2 |
| Application number | US-201615134016-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 20, 2016 |
| Priority date | Oct 20, 2009 |
| Publication date | Feb 20, 2018 |
| Grant date | Feb 20, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention relates to compounds represented by formula (I): wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.
Opening claim text (preview).
We claim: 1. A method of treating obesity, comprising administering to a mammal in need thereof a therapeutically effective amount of the compound: or a pharmaceutically acceptable salt thereof. 2. A method of treating obesity, comprising administering to a mammal in need thereof a therapeutically effective amount of the compound: or a pharmaceutically acceptable salt thereof. 3. A method of treating obesity, comprising administering to a mammal in need thereof a therapeutically effective amount of the compound: or a pharmaceutically acceptable salt thereof. 4. A method of treating obesity, comprising administering to a mammal in need thereof a therapeutically effective amount of the compound: or a pharmaceutically acceptable salt thereof.
Related publications grouped by family.
Answers are generated from the same data shown on this page.